is a leader in the field of regenerative medicine. This
field has the potential to revolutionize healthcare
by providing permanent replacements for damaged or diseased
tissues in unlimited supply. Our vision is to provide
the pivotal technologies required to make the area of
regenerative medicine a clinical success. These technologies
will provide the platform for the development of innovative
products that deliver patient benefits in important
and challenging areas of medicine.
A key concept in regenerative medicine is the provision
of a ‘scaffold’ that creates an optimised
environment, or a “regenerative niche” around
cells, enabling tissue regeneration to occur in clinical
situations in which the body’s natural repair
processes have failed.
RegenTec has developed a family of injectable
scaffolds that solidify within the body and can
be used to support tissue growth and deliver cells or
protein therapies via minimally invasive surgical procedures.
Major advantages of this core technology include:
- localised delivery,
- macroporous internal architectures,
- controllable biodegradation.
Our in-house development programmes are focussed upon
orthopaedics. Joint ventures are sought in other clinical
RegenTec also offer service activities to clients,
primarily in the translation of tissue engineering and
regenerative medicine concepts into the development
of drug testing assays.
The potential of this approach results from the fact
that tissues generally display more complex and physiologically
relevant functions when compared with a simple collection